ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 751

Dissecting the Heterogeneity of Skin Gene Expression Patterns in Systemic Sclerosis

Shervin Assassi1, William Swindell2, Minghua Wu1, Filemon K. Tan1, Dinesh Khanna3, Daniel E. Furst4, Donald Tashkin5, Richard Jahan-Tigh6, Maureen D Mayes1, Johann Gudjonsson2 and Jeffrey T. Chang6, 1Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 2Dermatology, University of Michigan, Ann Arbor, MI, 3University of Michigan, Ann Arbor, MI, 4University of California at Los Angeles, Los Angeles, CA, 5Medicine, University of California at Los Angeles, Los Angeles, CA, 6University of Texas Health Science Center at Houston, Houston, TX

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: cell biology, Gene Expression, skin fibrosis and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose:  To examine the heterogeneity of global transcriptome patterns in systemic sclerosis (SSc) skin from a large cohort of patients and controls.

Methods: Skin biopsies from 61 patients (70.5 % diffuse cutaneous involvement) enrolled in the GENISOS cohort or at the baseline visit of an imatinib study, as well as 36 unaffected controls of similar demographic background, were examined by Illumina HT-12 gene expression arrays. Follow-up q-PCR and immunohistochemistry experiments were also performed.   Using a novel analytic approach based on expression profiles, we investigated how heterogeneity within SSc samples relates to specific disease-relevant cell types (e.g. fibroblasts or macrophages). 

Results: We identified 2754 differentially expressed transcripts in SSc patients compared to controls.  Clustering analysis revealed two prominent transcriptomes in SSc patients: Keratin and fibro-inflammatory signatures.  Higher keratin transcript scores were associated with shorter disease duration and interstitial lung disease while higher fibro-inflammatory scores were associated with diffuse cutaneous involvement, higher skin score at biopsy site and higher modified Rodnan Skin Score.  There were no significant associations with disease-related autoantibodies or concomitant treatment with immunosuppressive agents.  A subgroup of patients with significantly longer disease duration had a normal-like transcript pattern. 

Further analysis and immunohistochemistry staining indicated that the above-mentioned keratin signature was not a general marker of keratinocyte activation, but was in fact associated with an activation pattern in hair and adnexal structures.

As shown in Figure 1, analysis of cell type-specific signature scores revealed remarkable heterogeneity across patients (each row represents a patient sample).  Significantly high scores were observed in the majority of patients for fibroblasts (72% of patients), microvascular (61%), and macrophages (54%). The majority of samples with significant fibroblast scores (35 of 44 = 80%) also had significantly increased macrophage and/or dendritic cell scores. Only a minority of samples showed significantly high CD4+ T-cell, CD8+ T-cell and plasma cell scores (18%, 21%, and 26%). 

Conclusion: In this large gene expression data set, a prominent keratin signature was present in addition to a fibro-inflammatory signature, supporting the notion that molecular dysregulations in SSc skin are not confined to the dermal layer but are in fact present in several skin compartments. Furthermore, the novel cell-specific transcript analysis showed significant heterogeneity of inflammatory profiles from SSc skin, which might be useful for stratifying patients for targeted treatment and/or predicting their response to immunosuppression. 

 


Disclosure:

S. Assassi,
None;

W. Swindell,
None;

M. Wu,
None;

F. K. Tan,
None;

D. Khanna,
None;

D. E. Furst,
None;

D. Tashkin,
None;

R. Jahan-Tigh,
None;

M. D. Mayes,
None;

J. Gudjonsson,
None;

J. T. Chang,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dissecting-the-heterogeneity-of-skin-gene-expression-patterns-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology